NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球末稍血管設備市場 - 預測(2021年∼2026年)

Global Peripheral Vascular Devices Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023189
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
全球末稍血管設備市場 - 預測(2021年∼2026年) Global Peripheral Vascular Devices Market - Forecasts from 2021 to 2026
出版日期: 2021年07月08日內容資訊: 英文 112 Pages
簡介

全球末稍血管設備的市場規模,預計從2019年的49億8800萬美元到2026年達到68億4900萬美元,在預期期間以4.63%的年複合成長率發展。

根據美國國立衛生研究院的資料,預計全球老年人口的成長將在未來幾年推動全球末稍血管設備市場的成長,每20名50歲或以上的美國人中就有一個患有末稍動脈疾病。統計資料顯示末稍動脈疾病的數量正以更快的速度成長,最終有望推動末稍血管設備市場的成長。

本報告提供全球末稍血管設備市場調查,市場概要,市場成長要素和阻礙因素,企業間的競爭關係,在各類型、各終端用戶、各地區的市場分析等資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 前提條件

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特的五力分析
    • 供給企業的競爭力
    • 買主的競爭力
    • 新加入業者的威脅
    • 替代品的威脅
    • 功能的競爭企業間的競爭關係
  • 功能價值鏈分析

第5章 各類型:末稍血管設備的市場分析

  • 簡介
  • 末梢血管支架
  • 經皮血管成形術(PTA)球囊導管
  • 經皮血管成形術(PTA)導管導引線
  • 栓塞保護設備
  • 其他

第6章 各終端用戶:末稍血管設備的市場分析

  • 簡介
  • 醫院及診療所
  • 門診病人手術中心

第7章 各地區:末稍血管設備的市場分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 其他
  • 中東和非洲
    • 以色列
    • 沙烏地阿拉伯
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第8章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 合併,收購,協定,共同研究
  • 供應商的競爭力 矩陣

第9章 企業簡介

  • Medtronic
  • Terumo
  • Abbott
  • Cordis
  • Biomerics
  • Cardiva Medical, Inc.
  • Vasorum Ltd
  • Biotronik GMBH & CO.KG
  • Boston Scientific Corporation
  • TZ Medical, Inc
目錄
Product Code: KSI061611749

The global peripheral vascular devices market is expected to grow at a compound annual growth rate of 4.63% over the forecast period to reach a market size of US$6.849 billion in 2026 from US$4.988 billion in 2019.

Peripheral vascular diseases (PVD) are caused by the formation of atherosclerotic plaques in arteries, which carry blood to organs, limbs, and the head. It is also known as peripheral artery occlusive disease (PAOD) or peripheral artery disease (PAD) or peripheral obliterative arteriopathy. It comprises diseases pertaining to both peripheral veins and peripheral arteries, affecting the peripheral and cardiac circulation in the body. Peripheral vascular devices like IVC channels, angiography catheters, EVAR stent-joins, hemodynamic stream change, and plague adjustment devices are utilized for treating peripheral blood vessel or coronary blood vessel infection and utilized in the peripheral endovascular and coronary methodology. These devices are used to decrease the interference of patients with a minimum disturbance during the surgical procedure.

The growing global geriatric population is expected to drive the global peripheral vascular devices market growth in the upcoming years as according to the National Institute of Health, one in every 20 Americans, who are of age 50 years or above, has PAD. It has been influencing 8-12 million individuals in the United States, particularly those for more than 50 years. Besides, as the populace is developing, the predominance of the infection is additionally expanding, which may develop from 9.6 million to arrive at 19 million generally, globally, by 2050. With the maturing global populace, all things considered, PAD might be progressively normal later on. Hence, the statistics show that the number of PAD is increasing at a faster pace, which is ultimately expected to drive the peripheral vascular devices market growth.

Some of the other drivers of this market include the global prevalence of venous diseases or CVI (Chronic Venous Insufficiency) and increasing demand for minimally invasive endovascular procedures on account of their shorter recovery time, among others. In addition, the growing prevalence of disease-causing lifestyle and eating habits such as high consumption of alcohol, tobacco products, and smoking cigarettes is expected to boost peripheral vascular devices market demand by triggering the incidence rates of cardiac arrest, blood clotting, and other vascular diseases. However, stringent regulations related to the import and export of peripheral vascular devices are expected to act as a restraint to this market growth.

Growth Factors.

  • Improvement of healthcare facilities in developing countries.

The interest for clinical devices in arising nations is developing at a hearty rate when contrasted with created nations (Source: International Trade Organization). The clinical instruments business in arising nations is expanding quickly because of the extension of the private medical care area to oblige the necessities of the developing working-class populace and the rising dispensable wages. The working-class populace in the Asia Pacific is relied upon to increment to 66% by 2030 from 28% in 2009, as per OECD. As indicated by a similar source, the buying force of the working class is relied upon to increment to 59% by 2020 from 23% in 2009. Because of these patterns, an expanding number of individuals in nations, for example, India and China are currently ready to bear the cost of cutting-edge medicines, including peripheral vascular diseases. Emerging markets such as China, India, Singapore, and Brazil are expected to witness high growth in the coming years owing to the presence of less-stringent regulatory policies and low competition. To leverage the high-growth opportunities in these markets, manufacturers are strategically focusing on expanding their presence in these countries. Moreover, the increasing competition in mature markets is further compelling manufacturers to focus on emerging markets.

Impact of COVID - 19.

Over the most recent couple of months, the quantity of patient visits to clinics has decreased essentially, regardless of crisis and OPD administrations being accessible in emergency clinics. Before beginning any interventional technique, specialists go through a progression of clinical tests to choose the best treatment for patients. Nonetheless, because of the lockdown in numerous nations, patient visits to medical clinics have decreased altogether. Therefore, the quantity of indicative tests has diminished. This has additionally diminished the deals of peripheral vascular devices. Globally, a larger part of nations has deferred elective medical procedures to forestall the spread of COVID-19. Since 70-80% of peripheral vascular interventional strategies are elective, a significant number of these systems have been postponed. This is another factor contrarily affecting the development of the peripheral vascular devices market. Additionally, shut assembling offices because of lockdowns disturbed stock chains, and diminished enlistments for clinical preliminaries have additionally affected the development of the global peripheral vascular devices market in 2020.

Competitive Insights.

Prominent/major key market players in the global peripheral vascular devices market include Medtronic, Terumo, Abbott, and Cordis among others. The players in the global peripheral vascular devices market are implementing various growth strategies to gain a competitive advantage over their competitors in this market. Major market players in the market have been covered along with their relative competitive strategies and the report also mentions recent deals and investments of different market players over the last few years. The company profiles section details the business overview, financial performance (public companies) for the past few years, key products and services being offered along with the recent deals and investments of these important players in the global peripheral vascular devices market.

Market Segmentation:

  • By Type
  • Peripheral Vascular Stents
  • Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
  • Peripheral Transluminal Angioplasty (PTA) Guidewires
  • Embolic Protection Devices
  • Others
  • By End-Users
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Israel
  • Saudi Arabia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Function
  • 4.4. Function Value Chain Analysis

5. Peripheral Vascular Devices Market Analysis, By Type

  • 5.1. Introduction
  • 5.2. Peripheral Vascular Stents
  • 5.3. Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
  • 5.4. Peripheral Transluminal Angioplasty (PTA) Guidewires
  • 5.5. Embolic Protection Devices
  • 5.6. Others

6. Peripheral Vascular Devices Market Analysis, By End-Users

  • 6.1. Introduction
  • 6.2. Hospitals and Clinics
  • 6.3. Ambulatory Surgical Centers

7. Peripheral Vascular Devices Market Analysis, By Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. UK
    • 7.4.2. Germany
    • 7.4.3. Italy
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. The Middle East and Africa
    • 7.5.1. Israel
    • 7.5.2. Saudi Arabia
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. Japan
    • 7.6.3. India
    • 7.6.4. Australia
    • 7.6.5. South Korea
    • 7.6.6. Taiwan
    • 7.6.7. Thailand
    • 7.6.8. Indonesia
    • 7.6.9. Others

8. Competitive Environment and Analysis

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. Company Profiles.

  • 9.1. Medtronic
  • 9.2. Terumo
  • 9.3. Abbott
  • 9.4. Cordis
  • 9.5. Biomerics
  • 9.6. Cardiva Medical, Inc.
  • 9.7. Vasorum Ltd
  • 9.8. Biotronik GMBH & CO.KG
  • 9.9. Boston Scientific Corporation
  • 9.10. TZ Medical, Inc